Lisha Tang Selected Research

pyramidatine

1/2018

Pyramidatine (Z88) Sensitizes Vincristine-Resistant Human Oral Cancer (KB/VCR) Cells to Chemotherapeutic Agents by Inhibition of P-glycoprotein.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lisha Tang Research Topics

Disease

4	Neoplasms (Cancer) 01/2018 - 12/2012
3	Ischemic Stroke 06/2022 - 01/2021
3	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 08/2021 - 01/2020
3	Liver Neoplasms (Liver Cancer) 02/2016 - 01/2015
2	Carcinogenesis 01/2022 - 01/2015
2	Habitual Abortion (Recurrent Miscarriage) 02/2021 - 01/2016
2	Mouth Neoplasms (Oral Cancer) 01/2018 - 12/2012
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022
1	Demyelinating Diseases (Demyelinating Disease) 08/2021
1	Carotid Artery Diseases 08/2021
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2021
1	Nervous System Diseases (Neurological Disorders) 01/2021
1	Parkinson Disease (Parkinson's Disease) 01/2021
1	Disease Progression 01/2021
1	Stroke (Strokes) 01/2021
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 03/2020
1	Adenocarcinoma 01/2018
1	Prostatic Neoplasms (Prostate Cancer) 01/2017
1	Breast Neoplasms (Breast Cancer) 12/2012

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 08/2021 - 12/2012
2	Biological ProductsIBA 01/2022 - 02/2016
2	AutoantibodiesIBA 08/2021 - 01/2021
2	Intravenous Immunoglobulins (IVIG)FDA Link 01/2021 - 01/2020
2	Vincristine (Oncovin)FDA LinkGeneric 01/2018 - 12/2012
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2018 - 12/2012
1	Tissue Plasminogen Activator (Alteplase)FDA Link 06/2022
1	NucleophosminIBA 01/2022
1	N-methyladenosineIBA 01/2022
1	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 08/2021
1	Sp1 Transcription FactorIBA 02/2021
1	Tirofiban (Aggrastat)FDA Link 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020
1	pyramidatineIBA 01/2018
1	cinnamic acidIBA 01/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018
1	Poly Adenosine Diphosphate RiboseIBA 02/2016
1	Caspase 3 (Caspase-3)IBA 02/2016
1	glaucocalyxin AIBA 02/2016
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2016
1	MicroRNAs (MicroRNA)IBA 01/2016
1	shizukaol DIBA 01/2016
1	SesquiterpenesIBA 01/2016
1	Aurora Kinase BIBA 01/2015
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2015
1	Histones (Histone)IBA 01/2015
1	gypenosideIBA 12/2012
1	multidrug resistance-associated protein 1IBA 12/2012
1	RNA (Ribonucleic Acid)IBA 12/2012

Therapy/Procedure

3	Therapeutics 01/2021 - 01/2018
1	Immunomodulation 01/2020
1	Hematopoietic Stem Cell Transplantation 01/2020
1	Plasma Exchange 01/2020
1	Drug Therapy (Chemotherapy) 12/2012